Robert Wessman
Wessman has led Alvogen from being a small US base
Alvogen has received multiple industry recognitions
Harvard Medical School
United States of America
Biography
As founder and CEO, Wessman has led Alvogen from being a small US based contract manufacturing business to becoming a top 15 global generics player operating in 35 countries in only six years.
Research Interest
Companies led by Wessman have a collective CAGR of more than 60 percent. He has led over 50 strategic acquisitions and partnerships and established operations in over 60 countries around the globe. These companies have achieved very strong organic growth in combination with external growth. Wessman’s achievements have made him the subject of two Harvard Business School Case Studies, titled “Robert Wessman and the Actavis Winning Formula” (2008) and “Alvogen” (2015). ONTACT
